Researcher holding up a culture dish in each hand

Search newsletter

What's inside? See our first ever special edition of Search which is in addition to our twice-yearly newsletters.

In this special summer edition of Search, we take an in depth look at the work our scientists are doing in bringing new treatments to people with cancer, who are at the heart of everything we do.

You can find out more about the importance of understanding the biology of cancer. By unravelling cancer’s secrets, our scientists will have a better idea of how cancer develops, spreads and becomes resistant to treatment, which will help them find new ways to prevent and treat the disease.

We then dive into drug discovery, explaining why protein degradation has the potential to lead to new treatments for hard-to-treat cancers and showcasing a recent advance that will help our structural biologists make further discoveries.

For instant access to our latest special issue of Search, simply subscribe by completing the form below.

Sign up now to receive Search

"I look forward to getting my copy of Search. It’s great to read all about the excellent work that the ICR does and it reminds me why I decided to support them in the first place."
- James Wilding, donor

Newsletter archive

Search issue 51 - Spring 2025

Find out how our scientists are developing improved breast cancer tools that will help identify women at high risk and our pioneering trial to test multiple treatments for brain cancer.

Download issue 51 (PDF)

Search issue 50 - Autumn 2024

In our 50th edition of the Autumn Search issue, we look at the latest research news featuring a new breast cancer drug approval in the UK, for treating the most common type of advanced breast cancer.

Download issue 50 (PDF)

Search issue 49 – Spring 2024

Look at how our researchers received a prestigious Queen's Anniversary Prize on behalf of the ICR, in recognition of our transformational breast cancer research programme.

Download issue 49 (PDF)

Search issue 48 – Autumn 2023

Find out how we're transforming treatment for people with cancers of unmet need, and meet our family charity partner Siobhan's Superstar Legacy, whose generous donation is supporting the work of our new Team Leader in Developmental Oncology, Dr Sally George.

Download issue 48 (PDF)

Search issue 47 – Spring 2023

Meet Dr Stephen-John Sammut, whose research uses AI to forecast how cancer is likely to respond to treatment, and find out more about capivasertib, a new promising drug born from the ICR’s cutting-edge science and pioneering programme of clinical trials.

Download issue 47 (PDF)

Search issue 46 – Autumn 2022

Meet the Director of our Centre for Evolution and Cancer, Professor Trevor Graham, whose research uses evolutionary principles and computational modelling to reveal how cancer develops.

Download issue 46 (PDF)

Search issue 45 – Spring 2022

Meet our new Team Leader, Dr Alex Radzisheuskaya, whose research focusses on how proteins help to package up DNA in cells – and the role that this can play in cancer.

Download issue 45 (PDF)

Silencing gene may combat formation of radiation-induced scar tissue, a new study reveals

04/06/25

A new study suggests that silencing CXCL12, a gene involved in tissue scarring and repair, could help reduce the formation of scar tissue that can caused by radiotherapy. Ultimately, the researchers hope this approach could improve treatment outcomes for breast cancer patients undergoing radiotherapy and reconstructive surgery.

See full story

ASCO 2025: One-time cell therapy offers long-term survival hope for patients with advanced melanoma

02/06/25

A one-time immunotherapy treatment using a patient’s own immune cells has shown long-lasting benefit for people with advanced melanoma, a serious form of skin cancer, according to new five-year follow-up data from a pivotal clinical trial.

See full story

ASCO 2025: Next-generation breast cancer drug targets tumours before they have a chance to grow

01/06/25

A powerful new drug for advanced breast cancer can be used to treat emerging tumours, months before they have a chance to grow, helping to keep patients well for longer and delaying the need for later-line therapies including chemotherapy. Results of a global study, funded by AstraZeneca and co-led by researchers at The Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Institut Curie, Paris, were presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on 1 June 2025.

See full story